Compounds > sri 62-834
Page last updated: 2024-09-03

sri 62-834 and Cell Transformation, Neoplastic

sri 62-834 has been researched along with Cell Transformation, Neoplastic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Handley, DA; Happy, J; Houlihan, WJ; Jaeggi, C; Lee, ML; Munder, PG; Nemecek, GM; Winslow, CM1

Other Studies

1 other study(ies) available for sri 62-834 and Cell Transformation, Neoplastic

ArticleYear
Antitumor activity of SRI 62-834, a cyclic ether analog of ET-18-OCH3.
    Lipids, 1987, Volume: 22, Issue:11

    Topics: Animals; Antineoplastic Agents; Cell Line; Cell Transformation, Neoplastic; Cytotoxins; Furans; Humans; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Phospholipid Ethers; Protein Kinase C; Receptors, Cell Surface; Receptors, Platelet-Derived Growth Factor; Tumor Cells, Cultured

1987